Omnicell, Inc. (OMCL): Price and Financial Metrics

Omnicell, Inc. (OMCL)

Today's Latest Price: $67.23 USD

2.00 (3.07%)

Updated Apr 6 6:55pm

Add OMCL to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 66 in Medical - Services

See all "A" rated Strong Buy stocks

OMCL Stock Summary

  • OMCL's current price/earnings ratio is 44.04, which is higher than 88.82% of US stocks with positive earnings.
  • With a year-over-year growth in debt of -25.66%, OMNICELL Inc's debt growth rate surpasses just 11.01% of about US stocks.
  • In terms of volatility of its share price, OMCL is more volatile than only 13.43% of stocks we're observing.
  • Stocks with similar financial metrics, market capitalization, and price volatility to OMNICELL Inc are SPSC, ECOM, TECH, SLP, and LNTH.
  • Visit OMCL's SEC page to see the company's official filings. To visit the company's web site, go to
OMCL Daily Price Range
OMCL 52-Week Price Range

OMCL Stock Price Chart More Charts

OMCL Price/Volume Stats

Current price $67.23 52-week high $94.85
Prev. close $65.23 52-week low $54.24
Day low $65.86 Volume 404,000
Day high $68.40 Avg. volume 276,085
50-day MA $77.19 Dividend yield N/A
200-day MA $76.66 Market Cap 2.85B

Omnicell, Inc. (OMCL) Company Bio

Omnicell provides automation and business analytics software for patient-centric medication and supply management across the entire healthcare continuum, from the acute care hospital setting to post-acute skilled nursing and long-term care facilities to the home. The company was founded in 1992 and is based in Mountain View, California.

OMCL Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target:Forecasted Gain:

We started the process of determining a valid price forecast for OMNICELL Inc with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that OMNICELL Inc ranked in the 26th percentile in terms of potential gain offered. We should note, though, that all scenearios modelled for this stock suggest it is overvalued. As for the metrics that stood out in our discounted cash flow analysis of OMNICELL Inc, consider:

  • The company's balance sheet shows it gets 97% of its capital from equity, and 3% of its capital from debt. Notably, its equity weight is greater than 79.57% of US equities in the Technology sector yielding a positive free cash flow.
  • The business' balance sheet suggests that 3% of the company's capital is sourced from debt; this is greater than just 10.63% of the free cash flow producing stocks we're observing.
  • OMCL's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 2%; for context, that number is higher than 56.55% of tickers in our DCF set.

Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price

For other companies in the Technology that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as OMCL, try BHE, TDY, ASML, BLKB, and BR.

OMCL Latest News Stream

Event/TimeNews Detail
Loading, please wait...

OMCL Latest Social Stream

Loading social stream, please wait...

View Full OMCL Social Stream

OMCL Price Returns

1-mo -18.96%
3-mo -17.67%
6-mo -8.98%
1-year -16.68%
3-year 66.62%
5-year 89.27%
YTD -17.73%
2019 33.44%
2018 26.27%
2017 43.07%
2016 9.07%
2015 -6.16%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.6549 seconds.